-
Deconstructing Peripheral Neuropathy and Chemo BrainResearchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
-
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
-
Building BridgesAACR Scientist↔Survivor Program celebrates 25 years of sparking conversations between cancer patients and researchers.
by Thomas Celona
-
The State of Cancer Care and PregnancyAn expert panel at the AACR Annual Meeting discussed the difficult choices faced when cancer is diagnosed during a pregnancy and how recent laws have brought additional challenges.
by Eric Fitzsimmons
-
Decoding Disparities in Colorectal CancerPeople of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.
by Marci A. Landsmann
-
Nudging Our Way to Better Cancer CareResearchers use insights from behavioral economics to encourage taking recommended actions in health care.
by Kevin McLaughlin
-
Post-surgery Option for Liver CancerNew study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
by Thomas Celona
-
Chronic Stress and CancerAccumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
by Thomas Celona
-
Forward Look
Progress in Personalized Cancer VaccinesStudy finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
by Thomas Celona
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
